1. SHPA Medal of Merit awarded for leadership in pharmacy education
SHPA President Professor Michael Dooley presented the SHPA Medal of Merit to Kirstie Galbraith during the opening plenary session of Medicines Management 2014, the 40th SHPA National Conference, being held in Darwin this weekend.
The SHPA Medal of Merit is awarded by SHPA’s Federal Council to a member of SHPA, in recognition of an outstanding recent contribution to the practice of hospital pharmacy or the professional development of pharmacy in the past 3 years.
Kirstie is a Fellow of SHPA and received the SHPA Australian Clinical Pharmacy Award in 2006. She is well known for her work and leadership in clinical pharmacy but more recently has been an outstanding leader in education, including in the emerging area of recognition of advanced pharmacy practice. Her current position is Director of the Postgraduate Studies and Professional Development Unit in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University.
Kirstie was one of the first pharmacists to combine clinical work with academia, working as a senior hospital pharmacist at the Royal Melbourne Hospital and as an academic at Monash University.
Kirstie’s achievements include introducing major changes to the delivery and accessibility of postgraduate education for pharmacists, which have contributed to the quality of clinical pharmacy services available to Australian consumers. Kirstie was instrumental in bringing together four Australian pharmacy schools to form an alliance – the National Alliance for Pharmacy Education (NAPE). Through this alliance, Kirstie is involved in educating pharmacists throughout their career journey – from intern training program, postgraduate qualifications, work in the advanced practice arena, and collaborating with SHPA to offer an alternative pathway for pharmacists to be accredited to perform medication reviews.
One of Kirstie’s most significant accomplishments, which will have lasting impacts on the profession, is her work in advanced pharmacy practice at local, state, national and international levels. She has participated in SHPA’s work on advanced practice, has been a member of the Advanced Pharmacy Practice Framework Steering Committee and has been appointed to the inaugural Australian Pharmacy Council Advanced Practice Credentialing Committee. On the international stage, Kirstie is the Domain Lead Competency (Advanced Practice) in the International Pharmaceutical Federation (FIP) Education Development Team.
Over many years, Kirstie has been an invaluable member of SHPA, contributing significantly to SHPA by her involvement in projects such as the Clinical Pharmacy Intervention Study; as a member of the Committee of Specialty Practice in Clinical Pharmacy; as part of the reference group that developed SHPA’s clinical competency assessment tool – shpaclinCAT; as part of SHPA’s committee working on advanced pharmacy practice; secretary of SHPA’s Victorian Branch Committee and much more. She is an engaging and sought after speaker and has presented at many national and international forums.
On presenting the award, Professor Dooley said “Kirstie’s drive and passion for clinical pharmacy and pharmacy education is impressive. Her contribution to the profession, which has international reach, makes her a worthy recipient of the inaugural SHPA Medal of Merit. Her work will have a long-term and major impact on pharmacy practice”.
2. Fred J Boyd Award 2014 awarded to Lloyd Sansom AO for distinguished contribution to quality use of medicines
During the opening day of Medicines Management 2014, the 40th SHPA National Conference, in Darwin this weekend, SHPA Federal President Professor Michael Dooley presented the 2014 Fred J Boyd Award to Emeritus Professor Lloyd Sansom AO.
The Fred J Boyd Award, named in honour of SHPA’s founding president, is SHPA’s highest honour. It is awarded to an individual of high professional ideals who has made significant contributions to hospital pharmacy that benefit hospital pharmacy, and through it, humanity and the public health.
It is clear from the catalogue of Lloyd’s accomplishments during his distinguished career as an educator, researcher and policy advisor that he is a deserving recipient. His outstanding and sustained contribution over decades has benefitted many Australian’s thanks to his influence relating to quality use of medicines; there is barely as aspect of pharmacy and medicines use in Australia in which he has not been involved nor had significant influence. With input and contribution to medicines committees at local, state and national levels, his influence is unparalleled.
A dynamic and visionary leader, Lloyd has had a major influence on pharmacy education and research. As head of School of Pharmacy and Medical Sciences at the University of South Australia, Lloyd instigated the transition of pharmacy education from a science focus to a clinical focus; introduced hospital-based clinical academics; was instrumental in establishing joint academic/hospital appointments and advanced the hospital research agenda. His contribution to research has been recognised by the establishment of the Sansom Research Institute for Health Research, University of South Australia.
As Chair of the Australian Pharmaceutical Advisory Council from 1991 to 2001, Lloyd was a driving force behind the Australian National Medicines Policy which underpins the Australian medicines system. The National Medicines Policy has four arms, Safety and Quality; Equity of Access; Quality Use of Medicines and A Responsible and Viable Pharmaceutical Industry. His contribution and commitment to quality use of medicines continues in his current roles as Special Advisor, National Medicines Policy Framework, Department of Health, and as Chair of the South Australian Medicines Advisory Committee.
Another of Lloyd’s notable achievements was to be the first pharmacist and longest serving chair of the Pharmaceutical Benefits Advisory Committee (PBAC).
In 2002 Lloyd was made an Officer of the Order of Australia for his “service to pharmacy in the development and implementation of “best practice” principles for the profession, medication management and education, and as a contributor to the development of national pharmaceutical policy”.
Lloyd continues to contribute to Australian health care via his numerous current appointments to professional and scientific authorities; Australian Pharmaceutical Formulary; Therapeutic Goods Administration; Pharmacy Board of Australia, Department of Health, Australian Commission on Safety and Quality in Health Care; Australian Pharmacy Examining Council; Australian Medicines Handbook; Australian Drug Evaluation Committee; as a member of the Journal of Pharmacy Practice and Research Editorial Advisory Board; and so much more.
On presenting the award, SHPA President Professor Michael Dooley said “It is a great privilege to present this award to Lloyd. His contribution to pharmacy and health care on so many levels is outstanding, but especially the influence he has had, and continues to have, on pharmacy practice and medicines policy.”